Fig. 2: Median three-year survival with single-agent dinutuximab beta.

Kaplan–Meier estimates for progression-free survival (a), overall survival (b), progression-free survival by disease status (c), and overall survival by disease status (d). OS overall survival, PFS progression-free survival, MNR median not reached, y years.